Data Shows Combo Stent May Offer Advantages to Current Technologies

OrbusNeich announced that pre-clinical data involving porcine coronary models demonstrate that the company’s Combo Bio-engineered Sirolimus Eluting Stent (Combo Stent) may offer advantages to the Cypher sirolimus eluting stent and the XIENCE V everolimus eluting stent.
redOrbit